NSE · TORNTPHARM.NS
Torrent Pharmaceuticals Limited
₹4,613.40+₹33.40 (+0.73%)
Torrent Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 12.13% below the high.
Loading market information…
NSE · PFIZER.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Pfizer Limited’s quoted price sits in the lower half of its reported 52-week range, 30.96% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Pfizer Limited’s forward annual dividend is ₹10.00 per share, paid annual. The forward yield is 0.27% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Pfizer Limited’s next earnings report is currently expected on Nov 3, 2026, with estimated earnings per share of ₹53.23. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Pfizer Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Pfizer Limited operates as a pharmaceutical company, engaged in the development, promotion, sale, and international export of medicinal products. Its diverse product range addresses numerous therapeutic needs, such as those related to the neuro/central nervous system, hormonal balance, cardiovascular health, hemophilia, infectious diseases, gynecology, pain relief, orthopedic conditions, oncology, urology, parasitic infections, gastrointestinal disorders, vaccinations, respiratory ailments, and nutritional supplements. The company markets its offerings predominantly under various brand names through an extensive network of independent distributors. Established in 1950, its corporate headquarters are situated in Mumbai, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:49 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2025 |
|---|
| May 19, 2025 |
| ₹41.87+16.79% vs estimate |
| ₹5.90B+1.25% vs estimate |
| Q3 2025 | Jan 31, 2025 | ₹27.90-12.26% vs estimate | ₹5.38B-5.56% vs estimate |
|---|
| Q2 2025 | Oct 28, 2024 | ₹34.60-6.49% vs estimate | ₹5.89B-5.4% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹4,613.40+₹33.40 (+0.73%)
Torrent Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 12.13% below the high.
₹1,352.00+₹7.00 (+0.52%)
Dr. Reddy's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 4.45% below the high.
₹1,378.90+₹20.90 (+1.54%)
Cipla Limited’s quoted price sits in the lower half of its reported 52-week range, 13.46% below the high.
₹2,492.80+₹23.50 (+0.95%)
Mankind Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 5.65% below the high.
₹25,750.00-₹395.00 (-1.51%)
Abbott India Limited’s quoted price sits in the lower half of its reported 52-week range, 16.0% below the high.
₹1,929.60+₹3.40 (+0.18%)
Ipca Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 5.32% below the high.
₹3,462.00+₹2.30 (+0.07%)
Ajanta Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 8.8% below the high.
₹2,508.70-₹6.40 (-0.25%)
GlaxoSmithKline Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 19.61% below the high.
